Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase II Trial Of Lapatinib And Pazopanib For Patients With Recurrent Glioblastoma Multiforme (GBM)

A Phase II Trial Of Lapatinib And Pazopanib For Patients With Recurrent Glioblastoma Multiforme (GBM). Society For Neuro-Oncology 12th Annual Meeting. 2007.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.